Showing 1 - 20 results of 28 for search 'Frank M Laferla', query time: 0.07s
Refine Results
-
1
-
2
-
3
Subcellular Mechanisms of Presenilin-Mediated Enhancement of Calcium Signaling by Malcolm A. Leissring, Frank M. LaFerla, Nick Callamaras, Ian Parker
Published 2001-06-01
Article -
4
-
5
-
6
-
7
BrightFocus Alzheimer’s Fast Track 2019 by Keith W. Whitaker, Frank M. LaFerla, Harry W. M. Steinbusch, Cynthia A. Lemere, Diane E. Bovenkamp
Published 2019-12-01
Article -
8
MTH1 and OGG1 maintain a low level of 8-oxoguanine in Alzheimer's brain, and prevent the progression of Alzheimer's pathogenesis by Sugako Oka, Julio Leon, Kunihiko Sakumi, Nona Abolhassani, Zijing Sheng, Daisuke Tsuchimoto, Frank M. LaFerla, Yusaku Nakabeppu
Published 2021-03-01
Article -
9
7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. by Nicholas A Castello, Michael H Nguyen, Jenny D Tran, David Cheng, Kim N Green, Frank M LaFerla
Published 2014-01-01
Article -
10
Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease by Veerendra Kumar Madala Halagappa, Zhihong Guo, Michelle Pearson, Yasuji Matsuoka, Roy G. Cutler, Frank M. LaFerla, Mark P. Mattson
Published 2007-04-01
Article -
11
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease by Syed Faraz Kazim, Julie Blanchard, Chun-Ling Dai, Yunn-Chyn Tung, Frank M. LaFerla, Inge-Grundke Iqbal, Khalid Iqbal
Published 2014-11-01
Article -
12
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar olig... by Justyna Sosna, Stephan Philipp, Ricardo Albay, Jorge Mauricio Reyes-Ruiz, David Baglietto-Vargas, Frank M. LaFerla, Charles G. Glabe
Published 2018-03-01
Article -
13
-
14
-
15
-
16
-
17
Correction: Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models by Mathew Blurton-Jones, Brian Spencer, Sara Michael, Nicholas A. Castello, Andranik A. Agazaryan, Joy L. Davis, Franz-Josef Müller, Jeanne F. Loring, Eliezer Masliah, Frank M. LaFerla
Published 2024-03-01
Article -
18
Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease. by Yanxing Chen, Zhu Tian, Zhihou Liang, Shenggang Sun, Chun-Ling Dai, Moon H Lee, Frank M LaFerla, Inge Grundke-Iqbal, Khalid Iqbal, Fei Liu, Cheng-Xin Gong
Published 2012-01-01
Article -
19
Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis by Heather M. Terron, Sagar J. Parikh, Samer O. Abdul-Hay, Tomoko Sahara, Dongcheul Kang, Dennis W. Dickson, Paul Saftig, Frank M. LaFerla, Shelley Lane, Malcolm A. Leissring
Published 2024-04-01
Article -
20
The collagen chaperone HSP47 is a new interactor of APP that affects the levels of extracellular beta-amyloid peptides. by Federico T Bianchi, Paola Camera, Ugo Ala, Daniele Imperiale, Antonio Migheli, Enrica Boda, Filippo Tempia, Gaia Berto, Ylenia Bosio, Salvatore Oddo, Frank M LaFerla, Stefano Taraglio, Carlos G Dotti, Ferdinando Di Cunto
Published 2011-01-01
Article